Cite

HARVARD Citation

    Sandborn, W. et al. (n.d.). P466 Tofacitinib for the treatment of ulcerative colitis: Up to 5.4 years of safety data from global clinical trials. Journal of Crohn's and colitis. p. S344. [Online]. 
  
Back to record